Olema (OLMA) traded up 3.28 % during a 24 hours period ending at 09:41 AM Central Europe on Tuesday 27th. One Olema stock can currently be bought for about USD 6.62 on popular exchanges. Current supply of Olema stocks is 88 mn. Olema has a current market capitalization of USD 589.7 mn and approximately USD 13.2 mn worth of Olema was traded on exchanges in the last 24 hours. Since last month end, Olema has traded -23.11 % down. Simple moving average of last 200 days is at USD 14.45. The highest price of past 52 weeks was recorded at USD 36.26 on 12/16/2025. 52 weeks low was at USD 6.24 on 10/23/2026.

Summary of the latest news for Olema

Olema Pharmaceuticals Inc. announced a change in its board composition following a voluntary resignation. The company’s management will appoint a new board member to replace the departing individual, with the new appointment confirmed for a term that will last until mid‑2029. This adjustment reflects the company’s ongoing efforts to maintain a stable governance structure. No additional operational or financial developments were disclosed in the announcement.

Here is how related stocks have performed in the past 24 hours:

  • Bally’s (BALY) traded down -2.81 % and now trades at USD 13.47. Current market capitalisation for Bally’s is USD 699.5 mn.

  • Movado (MOV) traded down -1.59 % and now trades at USD 30.96. Current market capitalisation for Movado is USD 705.5 mn. Movado has a current price to earnings ratio of 17.42.

  • Dakota Gold (DC) traded down -1.52 % and now trades at USD 5.19. Current market capitalisation for Dakota Gold is USD 707.1 mn.

  • Petco Health And Wellness (WOOF) traded up 1.63 % and now trades at USD 2.49. Petco Health And Wellness has a market capitalisation of USD 701.7 mn. Current price/earnings ratio for Petco Health And Wellness is 24.43.

  • Green Dot (GDOT) traded down -1.86 % and now trades at USD 12.13. Green Dot has a market capitalisation of USD 703.2 mn.

About Olema

Olema Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company based in San Francisco, United States. The company specializes in the discovery, development, and commercialization of next-generation targeted therapies for women’s cancers. Olema serves patients and healthcare professionals nationwide.